Humana Inc. (NYSE:HUM) Shares Bought by Metis Global Partners LLC

Metis Global Partners LLC grew its stake in shares of Humana Inc. (NYSE:HUM) by 4.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,237 shares of the insurance provider’s stock after purchasing an additional 235 shares during the quarter. Metis Global Partners LLC’s holdings in Humana were worth $1,329,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HUM. Creative Financial Designs Inc. ADV raised its holdings in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares in the last quarter. FPC Investment Advisory Inc. purchased a new position in shares of Humana during the fourth quarter worth approximately $27,000. Centricity Wealth Management LLC purchased a new position in shares of Humana during the fourth quarter worth approximately $30,000. Ashton Thomas Securities LLC purchased a new position in shares of Humana during the third quarter worth approximately $31,000. Finally, Atwood & Palmer Inc. grew its position in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 60 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on HUM shares. Piper Sandler raised their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. TD Cowen raised their target price on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Barclays raised their target price on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Finally, StockNews.com upgraded shares of Humana from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th. Nineteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $285.68.

Humana Price Performance

Shares of NYSE HUM opened at $261.65 on Tuesday. The firm has a market capitalization of $31.57 billion, a P/E ratio of 26.30, a PEG ratio of 2.05 and a beta of 0.56. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company’s fifty day moving average is $271.23 and its two-hundred day moving average is $285.69. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.